T

Alaunos Therapeutics
D

TCRT

3.36000
USD
-0.09
(-2.61%)
مغلق
حجم التداول
2,009
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
7,498,945
أصول ذات صلة الأخبار المقالات

العنوان: Alaunos Therapeutics Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.